Stock Chart
ACLX
$114.66
+0.07%
Score:
57.3
HOLD
LEAPs:
SELL
$110
LEAPs Option Signal
Type: SELL wallstreet
Strike: $110
Premium: $5.10
Expiry: Jan 15, 2027
Target: $111
Score: -79
LEAPs are long-term options (1+ year) with less time decay.
Type: SELL wallstreet
Strike: $110
Premium: $5.10
Expiry: Jan 15, 2027
Target: $111
Score: -79
LEAPs are long-term options (1+ year) with less time decay.
30D Target:
$114.67 - $116.46
STRONG_UPTREND
30D Trendline Target
This is a PROJECTED price range based on extrapolating the current trendline slope forward 30 days.
How it works:
• Draws support and resistance trendlines
• Calculates slope (rate of change)
• Projects lines to 30 days future
Signals:
● STRONG_UPTREND: Steep rise
● UPTREND: Moderate rise
● SIDEWAYS: Flat/Mixed
● DOWNTREND: Falling
⚠️ Not a prediction. Shows trend projection only.
R-squared: 0.27
This is a PROJECTED price range based on extrapolating the current trendline slope forward 30 days.
How it works:
• Draws support and resistance trendlines
• Calculates slope (rate of change)
• Projects lines to 30 days future
Signals:
● STRONG_UPTREND: Steep rise
● UPTREND: Moderate rise
● SIDEWAYS: Flat/Mixed
● DOWNTREND: Falling
⚠️ Not a prediction. Shows trend projection only.
R-squared: 0.27
Vol:
0.11x
(vs SPY: 0.6x | vs QQQ: 0.5x)
Volume Ratio Explained
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER
About ACLX - Arcellx, Inc. Common Stock
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
Key Statistics
Market Cap
$7B
More ACLX Analysis
This ACLX stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track ACLX's price movements with trendlines, gamma walls, and key support/resistance levels.